Prot #D8410C00001: A Modular Phase I/IIa, Open‐label, Multi‐centre Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of Ascending Doses of AZD9574 as Monotherapy and in Combination with Anti‐cancer Age

Project: Research project

Project Details

StatusActive
Effective start/end date9/29/23 → 9/29/26

Funding

  • Parexel (Prot #D8410C00001 // Prot #D8410C00001)
  • AstraZeneca Pharmaceuticals LP (Prot #D8410C00001 // Prot #D8410C00001)